Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

AH-001 could be a safer and more effective treatment for hair loss.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

The study identified key immune cell differences between mild and severe alopecia areata.

Some hair proteins are specific to hair, while others are also found in skin cells.

People with androgenetic alopecia have a higher risk of heart disease.

Women with hair loss have more androgen receptors in certain hair follicles.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Higher serum androgens contribute to male pattern baldness.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

People with early onset baldness (AGA) have higher blood sugar levels and lower sex hormone-binding globulin (SHBG) levels, suggesting SHBG could predict high blood sugar in these individuals.

The Fas/FasL pathway may play a role in alopecia areata.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

MCHR2 gene duplications may be linked to alopecia areata.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Certain proteins are essential for the growth of root hairs in barley.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

AgK114 protein helps in hamster skin injury recovery.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Alopecia areata involves immune response and gene changes affecting hair loss.